Logos Global Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Logos Global Management's NBIX Position: Q3 2026 in Review
Logos Global Management opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 250,000 shares worth $35.5M. The stake represents 1.85% of the portfolio and ranks #19 among its holdings. This is a return to the name: Logos Global Management previously reported a position in NBIX as recently as Q2 2025.
Logos Global Management first reported a position in NBIX in Q1 2022 and has held it in 8 quarters since. The position peaked at $44.5M in Q1 2022. 773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Logos Global Management held 250,000 shares of Neurocrine Biosciences worth $35.5M as of Q3 2026.
- Neurocrine Biosciences was a new Logos Global Management position in Q3 2026.
- Neurocrine Biosciences made up 1.85% of Logos Global Management's portfolio in Q3 2026, its #19 holding.
- Logos Global Management first reported a position in Neurocrine Biosciences in Q1 2022 and has held it in 8 quarters since.
- Logos Global Management's Neurocrine Biosciences position peaked at $44.5M in Q1 2022.
- 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Logos Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.